Can you get tirzepatide from a compounding pharmacy?
Key Takeaways
Tirzepatide cannot be legally compounded in a U.S. pharmacy at this time. It has been removed from the FDA drug shortage list as of October 2, 2024. When drugs are in short supply, the FDA may allow temporary compounding of some medicines to allow patients to continue to access their treatments.
Tirzepatide is now widely available as a prescription medicine made by Eli Lilly under the brands names Mounjaro (for type 2 diabetes) and Zepbound (for weight loss and sleep apnea).
The FDA may allow temporary compounding of medicines during a drug shortage to allow patients to continue to access their needed therapies or if there is a proven medical necessity for an individual patient, such as a sensitivity to an inactive ingredient.
According to the drug shortages list from the FDA, injectable prescription tirzepatide is now available and is no longer in shortage.
Nationwide drug shortages occurred with tirzepatide in December 2022 due to high demand. Shortages of other drugs similar to it, such as semaglutide (Ozempic, Wegovy) have also occurred in the past, but are now resolved.
If you were previously using a compounded tirzepatide product, talk to your healthcare provider about getting the brand name medicine. Also, check with your insurance for coverage and call Lilly Support Services at 1-800-545-5979 to learn more about accessing these medications if cost is an issue.
What is tirzepatide approved for?
Tirzepatide (Mounjaro, Zepbound) is classified as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.
Zepbound
- Zepbound (tirzepatide) is approved by the FDA to reduce excess body weight and maintain weight loss long term in adults with obesity or overweight and at least one weight-related medical condition (like high cholesterol, high blood pressure, obstructive sleep apnea or heart disease).
- Zepbound is also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
To learn more about this use, review How does Zepbound help treat sleep apnea?
Zepbound helps you lose weight and maintain weight loss and should be combined with a reduced-calorie diet and exercise for either weight management or OSA.
Mounjaro
- Mounjaro (tirzepatide) is approved to be used together with diet and exercise to help lower blood sugar in adults with type 2 diabetes.
- It has also been shown in clinical trials to help with long-term weight loss when combined with diet and exercise, but it is not FDA-approved for this use specifically.
Tirzepatide injection is only available as a prescription brand name product. It comes in pre-filled single-dose pen injectors or single-dose vials for either Mounjaro or Zepbound. There are no generic options for tirzepatide in the U.S. and the active ingredient for compounding is not available from the manufacturer.
Can I still buy compounded tirzepatide?
As of March 2025, tirzepatide can no longer be legally compounded by pharmacies because the shortage of this medicine was resolved in 2024. The FDA states that a patient should not use a compounded product if an approved medication like Mounjaro or Zepbound is commercially available.
Eli Lilly, the manufacturer of tirzepatide states that they cannot validate the safety or effectiveness of products claiming to contain tirzepatide that are not their branded products (Mounjaro and Zepbound).
The FDA does not review compounded versions of prescription medications, including compounded tirzepatide, for safety, effectiveness or quality. Compounded drugs may pose a higher risk than approved drugs, as noted by the FDA.
On the other hand, the FDA does review medicine safety, effectiveness and manufacturing processes for drugs submitted for approval. Eli Lilly's brand name drug Mounjaro was first approved in May 2022 and Zepbound was approved in November 2023.
Counterfeit versions of these medicines have also been marketed illegally, as reported by the FDA. If you think you have received counterfeit tirzepatide (Mounjaro, Zepbound) or received it from an unauthorized source, contact your healthcare provider. Counterfeit drugs may contain the wrong medicine or impure ingredients - or too little, too much or no active ingredient at all.
Related questions
- Mounjaro vs Ozempic: Which is right for you?
- Zepbound vs Mounjaro: Comparison Guide for Weight Loss and Diabetes Treatment
- Why am I not losing weight on Mounjaro?
Side Effects: Compounded semaglutide example
In May 2023 the FDA raised some concerns about another compounded GLP-1 agonist, semaglutide (brands: Ozempic and Wegovy), a medicine similar to tirzepatide that was also in shortage.
According to the FDA there were reports of side effects (“adverse events”) in patients who used compounded version of semaglutide used to treat patients with type 2 diabetes, for cardiovascular risk reduction and for weight loss management.
The FDA also reported that some compounding pharmacies were using different salt forms of semaglutide as the active ingredient. These include semaglutide acetate and semaglutide sodium, products that are not approved by the FDA and are different from the active ingredients found in Ozempic or Wegovy.
The manufacturer of semaglutide, Novo Nordisk, was noted to be pursuing legal action against compounding pharmacies for selling adulterated and misbranded compounded drugs claiming to contain semaglutide.
If you are considering use of any compounded medication, speak to your healthcare provider first for the best advice for your medical condition.
What exactly is drug compounding?
Drug compounding is the process of combining, mixing, or changing ingredients to create a medication specific for the needs of an individual patient. Some people may receive a prescription for a compounded medicine because they need a special formulation or due to a drug shortage in their area.
Drug compounding is a legal and a well-accepted practice in the United States, often done by licensed pharmacists, physicians or other healthcare providers.
A compounded version of an approved drug may be formulated if it meets certain conditions in the Federal Food, Drug and Cosmetic (FD&C) Act. For example, if an approved drug is in shortage, a compounded version can be legally prepared. However, compounded drugs are not FDA-approved, and the agency does not verify the safety or effectiveness of compounded drugs.
Compounded medications require a prescription from a healthcare provider. Licensed compounding pharmacies in the U.S. can legally prepare compounded medications when adhering to guidelines from the FDA and their State Board of Pharmacy. Patients should only obtain medicines from state-licensed pharmacies or facilities registered with the FDA.
Despite this, concerns have been raised about some drug compounding practices in the past, including sterility and other quality issues. The FDA has identified insanitary conditions at drug compounding facilities during inspections, which may result in contaminated products and serious patient injury and death.
FDA encourages health care professionals, patients, and pharmacies to report adverse events or quality problems with these or any medications to FDA’s MedWatch Adverse Event Reporting program.
This is not all the information you need to know about compounded tirzepatide for safe and effective use and does not take the place of your doctor’s directions. Discuss this information and any questions you have with your doctor or other health care provider.
References
- Compounding when Drugs are on FDA’s Drug Shortages List. 08/08/2025. US Food and Drug Administration (FDA). Accessed Sep 4, 2025 at https://www.fda.gov/drugs/human-drug-compounding/compounding-when-drugs-are-fdas-drug-shortages-list
- Understanding the Risks of Compounded Drugs. 12/18/2024. US Food and Drug Administration (FDA). Accessed Sep 4, 2025 at https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
- Human Drug Compounding. 5/15/2025. US Food and Drug Administration (FDA). Accessed Sep 4, 2025 at https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
- Novo Nordisk takes additional legal actions to help protect US patients from potentially unsafe and ineffective compounded drugs claiming to contain semaglutide that are not FDA approved. Press release. Nov. 30, 2023. Accessed Sep 4, 2025 at https://www.novomedlink.com/content/dam/novomedlink/semaglutide/November-30-2023-Company-Statement.pdf
- Lilly Statement on Mounjaro (tirzepatide) Compounding Litigation. Press release. Sept. 19, 2023. Accessed Sep 4, 2025 at https://investor.lilly.com/news-releases/news-release-details/lilly-statement-mounjaror-tirzepatide-compounding-litigation
- FDA Drug Shortages. US Food and Drug Administration (FDA). Accessed Sep 4, 2025 at https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
- FDA Approves First Medication for Obstructive Sleep Apnea. US Food and Drug Administration (FDA). Dec. 28, 2024. Press Announcements. Accessed Sep 4, 2025 at https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
- Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. US Food and Drug Administration (FDA). October 31, 2023. Accessed Sep 4, 2025 at https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
- Zepbound (tirzepatide) prescribing information. Eli Lilly & Co. Indianapolis, IN. Accessed Sep 4, 2025 at https://uspl.lilly.com/zepbound/zepbound.html#pi
- Mounjaro (tirzepatide) prescribing information. Eli Lilly & Co. Indianapolis, IN. Accessed Sep 4, 2025 at https://uspl.lilly.com/mounjaro/mounjaro.html#s7
Read next
Ozempic Mounjaro Wegovy & Zepbound: Weight Loss Compared
Ozempic, Mounjaro, Wegovy and Zepbound can all lead to long-term weight loss, but only Wegovy and Zepbound are approved by the FDA for this use. In studies, Zepbound has led to a 21% weight loss in adults using the highest dose, while Wegovy has led to about a 15% weight loss.
Continue reading
Which GLP-1 drug is best for weight loss?
The most effective GLP-1 drug for weight loss currently (as of mid-2025) is tirzepatide, marketed under the names Zepbound (for weight loss) and Mounjaro (for diabetes).
Continue reading
Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
There’s no evidence that hair loss is a direct side effect of Ozempic, Wegovy, Mounjaro or Zepbound. Hair loss is more likely due to the stress of rapid weight loss on your body, which can lead to temporary shedding of hair over several months, a condition known as telogen effluvium.
Continue readingSee also:
Related medical questions
- Can you switch between Ozempic and Mounjaro?
- How long does it take for Mounjaro to start working?
- Mounjaro side effects to be aware of
- Mounjaro constipation: Why it happens and how to get relief?
- How does Mounjaro Work for Weight Loss?
- Is Mounjaro covered by insurance or Medicare?
- Do GLP-1 drugs like Ozempic and Mounjaro cause sulfur burps?
- How long does Mounjaro stay in your system?
- Do you gain weight back after stopping Mounjaro?
- Where is the best place to inject Mounjaro?
- Does Mounjaro need to be refrigerated?
- Is there a best time of day to take Mounjaro?
- If Mounjaro has no diet plan, what food should you eat?
- Wegovy vs Mounjaro: Which works best for weight loss?
- Does Mounjaro cause blurry vision?
- Why does Mounjaro require a gradual increase in dosage?
- Does Mounjaro cause fatigue?
- What is the Mounjaro Coupon or Savings Card?
- Can I take antibiotics with Mounjaro?
- Is the Mounjaro injection painful?
- Trulicity vs Mounjaro: How do they compare?
- Can Zepbound and Mounjaro be used for heart failure?
- Ozempic Side Effects to Watch For
- Wegovy vs Ozempic: Which is Right for You?
- Tirzepatide vs semaglutide: How do they compare?
- Why am I not losing weight on Ozempic?
- Does Ozempic cause muscle loss and how to prevent it?
- How much does semaglutide cost?
- Where and how should Ozempic be injected?
- How does semaglutide work for weight loss?
Related support groups
- Mounjaro (55 questions, 128 members)
- Semaglutide (38 questions, 53 members)
- Zepbound (23 questions, 30 members)
- Ozempic (115 questions, 229 members)
- Wegovy (50 questions, 115 members)
- Tirzepatide (19 questions, 15 members)
- Weight Loss (Obesity/Overweight) (878 questions, 1,516 members)
- Diabetes, Type 2 (515 questions, 1,431 members)
- Cardiovascular Risk Reduction (102 questions, 28 members)
- Obstructive Sleep Apnea/Hypopnea Syndrome (26 questions, 56 members)
- Sleep Apnea (22 questions, 103 members)